Pricing our medicines to help ensure patient access
We know there is significant frustration in the US regarding the cost of healthcare – including prescription medicines. We take this very seriously, as evidenced by our pricing track record. In fact, the launch price of our six most recently introduced new medicines were priced similarly or less than the market leader. This illustrates our commitment to appropriately balance reward for our innovation and ensure broadest patient access.